companydata.dkcompanydata.dk

Pharma4ever QA ApS: Financial statements 2023

CVR: 39104644

Source: annual report 2023, Danish Business Authority

01/01/202331/12/2023

Pharma4ever QA ApS (CVR 39104644) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 8,616,787 and a net result of DKK 1,727,927 compared with DKK 1,995,694 the year before. That is an increase of 11.6% compared with the year before. Equity in the 2023 report amounted to DKK 1,814,264. The solvency ratio was 47%. The company had 6 employees in the financial year.

Gross Profit
DKK 8,616,787
Profit/Loss
DKK 1,727,927
Equity
DKK 1,814,264
Total Assets
DKK 3,861,385
Employees
6

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2023-8.6 mio.1.7 mio.1.8 mio.6
2022-7.7 mio.2 mio.2.1 mio.5
2021-5.9 mio.1.3 mio.1.3 mio.5
2020-6 mio.1.6 mio.1.7 mio.5
2019-4.9 mio.1.1 mio.1.2 mio.4

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2023

Pharma4ever QA ApS: The 2022 annual report is outJun 14, 2023

Pharma4ever QA ApS has published its annual report for 2022. Gross profit came to DKK 7,717,871, and the net result was DKK 1,995,694.

About Pharma4ever QA ApS

Pharma4ever QA ApS is a Danish company of the type Anpartsselskab based in Herlev, founded in 2017. The company is under bankruptcy. The company is registered under the industry Anden teknisk rådgivning. The company is owned by BHP Holding ApS, Andresen Holding af 29. maj 2015 ApS and SLP Holding 2017 ApS. The company has 3 employees (2018). In 2024, the company reported a gross profit of DKK 11,494,444 and a net result of DKK 2,507,255 compared with DKK 1,727,927 the year before. Equity in the 2024 report amounted to DKK 2,557,256.

Source: annual report 2024, Danish Business Authority

Other financial years